A row has broken out regarding the availability of drugs within the UK

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.517, 2006-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK Drug and Therapeutics Bulletin (DTB), has published a warning regarding the development and marketing of new forms of established drugs

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The UK Drug and Therapeutics Bulletin (DTB), has published a warning regarding the development and marketing of new forms of established drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 516, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

In the wake of recent study data, the UK MHRA has issued interim advice regarding concomitant use of clopidogrel and proton pump inhibitors

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pharmaceutical Policy regarding Generic Drugs in Belgium

By Simoens Steven

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 755-766

Adis International

Access to resources Recommend Favorite

There are serious concerns regarding shortages of prescription drugs in the US

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite